E.g. Ocyan's hypothesis that Dendreon knows when people came in for active P-11 boosters. Or the company might have other blood markers for those booster patients vs the 'boosters' for placebo patients (e.g. PSA Velocity). We have access to 10 pieces of data - Dendreon has access to 100's of pieces of data (none conclusive, but still a lot more info than we have)
In the same vein of knowing about the #'s of placebo and active boosters, it is very likely that they already have the ellapse times of the median and 75% percentile for the placebo population. The difference between these gives a reasonable estimate of the median PSAR. If that matches with historical median PSAR in various studies using Lupron and similar chemical castration drugs, i.e., between 6 to 8 months, that would be good to moderately good news. On the other hand, if that is much longer than 8 months as some have conjectured due to the single Lupron shot, that would be not so good news - yet.
